Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Aubrey Berger
Institution:
Mayo Clinic
Observed institution:
Mayo Clinic
ORCID:
0009-0005-1913-3502
Observed ORCID:
0009-0005-1913-3502
OpenAlex ID:
A5109699016
Retinal gene therapy using epiretinal AAV-containing fibrin hydrogel implants
2025
·
Brittni A. Scruggs
, Aubrey Berger
, et al.
·
Science Advances
·
8
PDF
Early Choriocapillaris Loss in a Porcine Model of RPE Cell Debridement Precedes Pathology That Simulates Advanced Macular Degeneration
2024
·
Raymond Iezzi
, Brittni A. Scruggs
, et al.
·
Investigative Ophthalmology & Visual Science
·
7
Retinal Viral Gene Therapy: Impact of Route of Administration on Serious Adverse Events—A Systematic Review
2025
·
Aubrey Berger
, Ciera D. Johnson
, et al.
·
Clinical and Experimental Ophthalmology
·
3
PDF
Feasibility and durability of a first-of-a-kind, sustainable biologic paint using bacterial pigment and protein binder
2026
·
Rathan Duggirala
, Aubrey Berger
, et al.
·
Journal of Coatings Technology and Research
·
1
Storage and Stability of AAV-Containing Fibrin Hydrogels for Retinal Gene Therapy
2026
·
Aubrey Berger
, Travis Knudsen
, et al.
·
Gels
Degradable fibrin hydrogels for transplantation of iPSC-derived retinal pigment epithelial cell monolayers
2026
·
Alan D. Marmorstein
, Brittni A. Scruggs
, et al.
·
Frontiers in Cell and Developmental Biology
PDF
Show more works
View as search
Works count:
6
Citation count:
19
H-index:
3
I10-index:
Year
Topic
Type
